Matthieu Leclerc-Chalvet

Matthieu Leclerc-Chalvet is the CEO of Therapixel, a position he has held since June 2019. He brings over 30 years of experience in the medical device industry, having previously served as the Managing Director at Mirada Medical from July 2014 to June 2019. During his tenure at Mirada, he successfully raised £6 million from Apposite Capital and achieved double-digit growth after a period of stagnation. He also established a strategic partnership with BTG plc, and led the launch of the first commercial AI product for radiation oncology.12

Leclerc-Chalvet has an extensive educational background, including a Doctor of Philosophy (PhD) in Business, Marketing, and Enterprise from the University of Hertfordshire, an MSc in Biomedical Engineering from Université Claude Bernard Lyon 1, and an Executive Programme in General Management from INSEAD.13

Before his role at Mirada Medical, he held significant positions at Smiths Medical, where he was the Vice President of Global Marketing for the Airway franchise, overseeing a substantial annual turnover and leading various strategic initiatives.13

At Therapixel, he is focused on developing AI-based software to assist radiologists in breast cancer diagnosis, contributing to innovations in medical imaging technology.45